Direxion Daily S&P Biotech Bull 3X ETF
LABU
28 hedge funds and large institutions have $26.6M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 2 closing their positions.
267% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 3
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
17% more funds holding
Funds holding: 24 → 28 (+4)
5% more capital invested
Capital invested by funds: $25.5M → $26.6M (+$1.17M)
0.05% more ownership
Funds ownership: 0.17% → 0.22% (+0.05%)
25% less call options, than puts
Call options by funds: $98.6M | Put options by funds: $132M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$7.47M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$3.46M |
| 3 |
CG
Cutler Group
San Francisco,
California
|
+$2.82M |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
+$1.51M |
| 5 |
Morgan Stanley
New York
|
+$1.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.4M |
| 2 |
Jane Street
New York
|
-$2.72M |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.46M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.09M |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $6K | – | – | – |
|
27
Barclays
London,
United Kingdom
| $4K | +$4.92K | +4 | New |
|
|
AWM
28
Activest Wealth Management
Aventure,
Florida
| $2K | – | – | – |
|
|
29
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$5.4M | -4,394 | Closed |
|
|
ASN
30
Advisory Services Network
Atlanta,
Georgia
| – | -$3K | -2 | Closed |
|
LABU Hedge Fund Activity: Q3 2021 in Review
28 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q3 2021, worth a combined $26.6M — up 4.6% from $25.5M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new LABU positions and 2 closed out — a net gain of 4 holders — while 11 added to existing stakes and 3 trimmed.
The largest buyer was HRT Financial, adding an estimated $7.47M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $5.4M sold.
- 28 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q3 2021, up from 24 in Q2 2021.
- Funds reported $26.6M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q3 2021, up 4.6% quarter-over-quarter.
- 6 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q3 2021 and 2 closed out, a net change of +4 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q3 2021 was HRT Financial, an estimated $7.47M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q3 2021 was Susquehanna International Group, an estimated $5.4M sold.
Based on aggregated 13F filings for Q3 2021.